SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (11686)9/21/2018 6:40:46 PM
From: Miljenko Zuanic  Read Replies (2) | Respond to of 12215
 
Tuck, this was peptide, fairly large ( pdfaiw.uspto.gov ), drawing p14

what route they are using, also dose range in P1? Stability? P1 safety will not bring them partner, IMO.



To: tuck who wrote (11686)9/21/2018 7:10:09 PM
From: scaram(o)uche  Respond to of 12215
 
You've seen this, correct?

Free Radic Biol Med. 2016 Nov;100:182-187. doi: 10.1016/j.freeradbiomed.2016.05.015. Epub 2016 May 20.

MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism.
Lee C1, Kim KH2, Cohen P3.

1
USC Leonard Davis School of Gerontology, 3715 McClintock Ave., Suite 103, Los Angeles, CA 90089, United States. Electronic address: changhan.lee@usc.edu.
2
USC Leonard Davis School of Gerontology, 3715 McClintock Ave., Suite 103, Los Angeles, CA 90089, United States.
3
USC Leonard Davis School of Gerontology, 3715 McClintock Ave., Suite 103, Los Angeles, CA 90089, United States. Electronic address: hassy@usc.edu.

Mitochondria are ancient organelles that are thought to have emerged from once free-living a-proto-bacteria. As such, they still possess several bacterial-like qualities, including a semi-autonomous genetic system, complete with an independent genome and a unique genetic code. The bacterial-like circular mitochondrial DNA (mtDNA) has been described to encode 37 genes, including 22 tRNAs, 2 rRNAs, and 13 mRNAs. Two additional peptides reported to originate from the mtDNA, namely humanin (Hashimoto et al., 2001; Ikone et al., 2003; Guo et al., 2003) [1-3] and MOTS-c (mitochondrial ORF of the twelve S c) (Lee et al., 2015) [4], indicate a larger mitochondrial genetic repertoire (Shokolenko and Alexeyev, 2015) [5]. These mitochondrial-derived peptides (MDPs) have profound and distinct biological activities and provide a paradigm-shifting concept of active mitochondrial-encoded signals that act at the cellular and organismal level (i.e. mitochondrial hormone) (da Cunha et al., 2015; Quiros et al., 2016) [6,7]. Considering that mitochondria are the single most important metabolic organelle, it is not surprising that these MDPs have metabolic actions. MOTS-c has been shown to target the skeletal muscle and enhance glucose metabolism. As such, MOTS-c has implications in the regulation of obesity, diabetes, exercise, and longevity, representing an entirely novel mitochondrial signaling mechanism to regulate metabolism within and between cells.

Price:book of ~ 8?? The power of merely mentioning nash, or ???

Every reference, search term "MOTS-c"....

ncbi.nlm.nih.gov



To: tuck who wrote (11686)9/21/2018 7:14:42 PM
From: scaram(o)uche  Respond to of 12215
 
From one of their old PRs.....

>> MENLO PARK, Calif.--(BUSINESS WIRE)-- CohBar, Inc. (TSX-V: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics to treat diseases associated with aging, today provided a corporate update and reported financial results for the full year ending December 31, 2014. <<

Humble beginnings.



To: tuck who wrote (11686)9/25/2018 2:08:34 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 12215
 
Do good companies issue these kinds of PRs? globenewswire.com